NeuroPace is an innovative medical device company dedicated to improving quality of life for individuals with medically refractory epilepsy. In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling neurological disorders that negatively impact quality of life for millions of patients throughout the world.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/24/17 | $74,000,000 |
KCK Group OrbiMed Advisors | undisclosed | |
| 08/31/20 | $67,000,000 |
Accelmed Partners KCK Group OrbiMed Advisors Revelation Partners Soleus Capital | undisclosed |
